Banque Pictet & Cie Sa Upped Molson Coors Brewing Co (TAP) Holding; Curis (CRIS) Shorts Up By 39.65%

Molson Coors Brewing Company (NYSE:TAP) Logo

Curis Inc (NASDAQ:CRIS) had an increase of 39.65% in short interest. CRIS’s SI was 1.28M shares in January as released by FINRA. Its up 39.65% from 914,100 shares previously. With 325,100 avg volume, 4 days are for Curis Inc (NASDAQ:CRIS)’s short sellers to cover CRIS’s short positions. The SI to Curis Inc’s float is 4.66%. The stock decreased 5.26% or $0.05 during the last trading session, reaching $0.9. About 107,755 shares traded. Curis, Inc. (NASDAQ:CRIS) has declined 83.59% since January 14, 2018 and is downtrending. It has underperformed by 83.59% the S&P500. Some Historical CRIS News: 31/05/2018 – Curis Announces FDA Fast Track Designation for Fimepinostat (CUDC-907) Development in Patients with Relapsed or Refractory Diff; 03/05/2018 – CURIS INC – AS OF MARCH 31, 2018, CURIS’S CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES AND INVESTMENTS TOTALED $48.5 MLN; 06/04/2018 – Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4); 24/05/2018 – Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development; 24/05/2018 – Curis Appoints Robert Martell as Head of Research and Development; 03/05/2018 – Curis 1Q Loss $10.7M; 22/03/2018 – CURIS INC – DENTZER BECAME CFO IN CONNECTION WITH ENTRANCE INTO AN AMENDED AND RESTATED EMPLOYMENT AGREEMENT; 31/05/2018 – /C O R R E C T l O N — Curis, Inc./; 03/05/2018 – Curis 1Q Loss/Shr 7c; 22/04/2018 – DJ Curis Inc, Inst Holders, 1Q 2018 (CRIS)

Banque Pictet & Cie Sa increased Molson Coors Brewing Co (TAP) stake by 127.77% reported in 2018Q3 SEC filing. Banque Pictet & Cie Sa acquired 12,777 shares as Molson Coors Brewing Co (TAP)’s stock declined 3.07%. The Banque Pictet & Cie Sa holds 22,777 shares with $1.40M value, up from 10,000 last quarter. Molson Coors Brewing Co now has $13.53B valuation. The stock decreased 1.14% or $0.72 during the last trading session, reaching $62.62. About 707,455 shares traded. Molson Coors Brewing Company (NYSE:TAP) has declined 21.53% since January 14, 2018 and is downtrending. It has underperformed by 21.53% the S&P500. Some Historical TAP News: 06/03/2018 Andrew Stordeur Joins Sundial’s Senior Leadership Team as Chief Commercial Officer; 02/05/2018 – Molson Coors Sees Underlying Effective Tax Rate in the Range of 18%-22 % for 2018; 01/04/2018 – MOLSON COORS MAY BE INTERESTED IN PARTS OF CONVIVIALITY: TIMES; 11/03/2018 – TEAMSTERS CANADA: MOLSON BREWERY WORKERS RATIFY NEW PACT; 16/03/2018 – Molson Coors Closes Below 50-Day Moving Average: Technicals; 02/05/2018 – MOLSON COORS 1Q UNDERLYING EPS 48C, EST. 77C; 02/05/2018 – Molson Coors Preliminary View of Its Long-Term Effective Tax Rate (after 2018) Is in the Range of 20%-24%; 23/04/2018 – DJ Molson Coors Brewing Company Class , Inst Holders, 1Q 2018 (TAP.A); 02/05/2018 – Molson Coors 1Q EPS $1.28; 23/04/2018 – DJ Molson Coors Brewing Company Class , Inst Holders, 1Q 2018 (TAP)

Since September 4, 2018, it had 0 insider buys, and 4 sales for $667,546 activity. $168,186 worth of Molson Coors Brewing Company (NYSE:TAP) was sold by Anand Krishnan on Thursday, November 1.

Among 7 analysts covering Molson Coors Brewing (NYSE:TAP), 4 have Buy rating, 1 Sell and 2 Hold. Therefore 57% are positive. Molson Coors Brewing had 8 analyst reports since August 2, 2018 according to SRatingsIntel. Citigroup maintained the shares of TAP in report on Monday, August 27 with “Buy” rating. Morgan Stanley maintained Molson Coors Brewing Company (NYSE:TAP) on Thursday, August 2 with “Equal-Weight” rating. The stock has “Positive” rating by Susquehanna on Thursday, August 2. The rating was maintained by Citigroup with “Buy” on Thursday, November 1.

Investors sentiment increased to 1.49 in Q3 2018. Its up 0.26, from 1.23 in 2018Q2. It is positive, as 42 investors sold TAP shares while 129 reduced holdings. 86 funds opened positions while 169 raised stakes. 154.13 million shares or 9.03% more from 141.37 million shares in 2018Q2 were reported. High Pointe Capital Mngmt Lc holds 0.8% or 9,690 shares. 7.56 million were reported by State Street. Putnam Investments Limited Company holds 2.38M shares. Virtu Limited Liability Co, New York-based fund reported 5,325 shares. Zwj Inv Counsel invested in 1.2% or 240,510 shares. Renaissance Tech Limited Liability Corp invested 0.03% of its portfolio in Molson Coors Brewing Company (NYSE:TAP). Quantres Asset Management Ltd has 0.17% invested in Molson Coors Brewing Company (NYSE:TAP). Amp Capital Investors holds 49,517 shares or 0.02% of its portfolio. Lord Abbett & Limited Liability Company holds 0.01% or 71,200 shares. Csat Inv Advisory Ltd Partnership owns 272 shares or 0.01% of their US portfolio. Dekabank Deutsche Girozentrale holds 0.03% in Molson Coors Brewing Company (NYSE:TAP) or 64,655 shares. Ny State Teachers Retirement Systems stated it has 309,781 shares or 0.04% of all its holdings. Highstreet Asset Mgmt Inc reported 6,195 shares. Nordea Mgmt stated it has 309,506 shares. Guardian Life Insur Communication Of America invested in 0.01% or 526 shares.

Banque Pictet & Cie Sa decreased Oracle Corp (NYSE:ORCL) stake by 25,621 shares to 240,556 valued at $12.40M in 2018Q3. It also reduced Fluor Corp New (NYSE:FLR) stake by 40,000 shares and now owns 35,000 shares. Ishares Tr (IBB) was reduced too.

More notable recent Molson Coors Brewing Company (NYSE:TAP) news were published by: Fool.com which released: “These 2 Pot Stocks Are Moving to the NYSE – The Motley Fool” on January 13, 2019, also Benzinga.com with their article: “Molson Coors On Track To Outperform Beer Peers, Susquehanna Says (NYSE:TAP) – Benzinga” published on January 07, 2019, Nasdaq.com published: “Breaking News: The Multi-Billion Dollar US and Canadian CBD-Infused Beverage Race is On: Tilray, Coca Cola, Molson Coors Brewing Co., Heineken and American Premium Water Corporation on Watch – Nasdaq” on January 14, 2019. More interesting news about Molson Coors Brewing Company (NYSE:TAP) were released by: Investorplace.com and their article: “7 Downtrodden Stocks to Fish From the Bottom – Investorplace.com” published on January 03, 2019 as well as Investorplace.com‘s news article titled: “Will Aurora Cannabis Be Next to Secure a Big Partnership? – Investorplace.com” with publication date: December 21, 2018.

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company has market cap of $29.80 million. The firm develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase II clinical trials for relapsed or refractory diffuse large B-cell lymphoma, as well as in Phase I clinical trials for patients with solid tumors; CA-170, an oral small molecule drug candidate that is in Phase I clinical trials in patients with advanced solid tumors and lymphomas; CA-4948, an oral small molecule drug candidate, which is in preclinical stage for the treatment of hematologic cancers; and CA-327, an oral small molecule drug candidate that is in preclinical stage for the treatment of cancers. It currently has negative earnings. It is also developing Erivedge, an orally-administered small molecule hedgehog pathway inhibitor for advanced basal cell carcinoma, idiopathic pulmonary fibrosis, and myelofibrosis.

Molson Coors Brewing Company (NYSE:TAP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.